RETROSPECTIVE ANALYSIS OF GENDER-AGE STRUCTURE AND COMORBID PATHOLOGY OF PATIENTS WITH VIRAL AND BACTERIAL PNEUMONIA ASSOCIATED WITH COVID-19
Keywords:viral and bacterial pneumonia, COVID-19, age, comorbidity, cardiovascular system
Background. In December 2019 first case of COVID-19 was first registered in Wuhan, Hubei province, China. This infectious disease primarily causes respiratory tract infection, but can also affect the other organs and systems.
Objective. In this study, the features of the gender-age structure and comorbid pathology of the patients with viral and bacterial pneumonia who were treated in inpatient department in the period from September to December 2020 are summarized.
Methods. The research was conducted in Ternopil Municipal Hospital No. 3, Ternopil, Ukraine. Clinical cases of 262 patients with viral and bacterial pneumonia associated with COVID-19 were studied retrospectively.
Results. Both men and women has been affected by this pathology in Ternopil region with the same frequency in contrast with the established fact that men are less resistant to infections that women. Most of the patients ranged in age from 51 to 70 years, however, a fair number of patients were over the age of 70 years. Concomitant pathology was diagnosed in 65.5% of the patients with coronavirus infection. Coronary heart disease (34.5%) is leading in the structure of comorbid conditions.
Conclusions. During the COVID-19 pandemic, timely diagnosis and medical care of the patients over 50 years of age is of great importance. The analysis of concomitant pathology proves that the people with cardiovascular pathology are in the increased risk group.
Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021 Dec 8:1-1.
Morato MM, Bastos SB, Cajueiro DO, Normey-Rico JE. An optimal predictive control strategy for COVID-19 (SARS-CoV-2) social distancing policies in Brazil. Annual reviews in control. 2020 Jan 1;50:417-31.
Hryhoruk P, Khrushch N, Grygoruk S, Grygoruk S, Prystupa L, Gorbatiuk K. Assessing the impact of COVID-19 pandemic on the regions’ socio-economic development: The case of Ukraine.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama. 2020 Aug 25;324(8):782-93.
Feshchenko YI, Gavrisyuk VK, Dziublyk IV, Dziublyk OY, Gumeniuk GL, Gumeniuk MI, Kapitan GB, Yachnik VA. Infectious exacerbation of chronic obstructive pulmonary disease: place and role of respiratory viral pathogens. Medicni perspektivi (Medical perspectives). 2019;24(4):30-5.
Kopcha VS. FEATURES OF IMMUNO-DEPENDENT MANIFESTATIONS AT COVID-19. ІХ [Internet]. 2021 Jun. 30 [cited 2021 Dec. 26];(2):4-16. Available from: https://ojs.tdmu.edu.ua/index.php/inf-patol/article/view/12159
World Health Organization. Clinical management of Covid-19: interim guidance. May 27.2020. Available online: https://www.who.int/publications/i/item/clinical-management-of-covid-19.
Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatric pulmonology. 2020 May;55(5):1169-74. DOI: 10.1002/ppul.24718.
Bwire GM. Coronavirus: why men are more vulnerable to Covid-19 than women?. SN comprehensive clinical medicine. 2020 Jul;2(7):874-6.
Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, Hu G, Wang Z, Zheng F, Wang L. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. Journal of medical virology. 2020 Oct; 92(10):2050-4.
Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA internal medicine. 2020 Nov 1; 180(11):1436-47.
Jakhmola S, Indari O, Baral B, Kashyap D, Varshney N, Das A, Chatterjee S, Jha HC. Comorbidity assessment is essential during COVID-19 treatment. Frontiers in physiology. 2020 Aug 4;11:984.
How to Cite
Copyright (c) 2022 International Journal of Medicine and Medical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).